HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Irvine-based Allergan Inc. asked a federal court in Santa Ana to block activist investor Bill Ackman and his Pershing Square Capital Management LP from voting its 10% stake at an upcoming special meeting.
San Clemente-based Vertiflex Inc. raised $6 million in funding, according to a filing with the Securities and Exchange Commission.
Fountain Valley-based MemorialCare Health System said today that its MemorialCare Medical Foundation is now the sole owner of eight imaging centers located in Orange County and Long Beach.
Edwards’ Weisner Kept Legal Aligned With Business Strategy in $1B+ Medtronic Case
Aimee Weisner was setting the strategy that led to Edwards Lifesciences Corp.’s $1 billion-plus patent lawsuit settlement against rival Medtronic Inc.
Credit some of Orange County’s biggest insurance brokers with quick adjustments to shifts in California’s corporate landscape.
Allergan GC Takes Team Approach for Near-Perfect Case Record
William Scarff Jr. concentrates on protecting the driving force in the drug industry: patents on major medications.
Allergan Inc. Chief Executive David Pyott has resigned as a director of Edwards Lifesciences Corp.
A federal jury said today that Irvine-based Masimo Corp. should receive $467 million from Philips Electronics NA, a unit of Netherlands-based Royal Philips Electronics NV, for having infringed a pair of patents covering technology for measuring blood oxygen and tracking pulse rates.
Irvine-based drug maker Allergan Inc. said the U.S. Food and Drug Administration approved its Ozurdex 0.7 mg biodegradable steroid implant for general use in treating diabetic macular edema.
Mission Viejo-based Ensign Group Inc. bought an assisted living facility in Tucson, Ariz., the company said.
HEALTHCARE: Bid for Allergan looks light despite last week’s stir
Did Valeant Pharmaceuticals International Inc. make David Pyott’s point last week?
Irvine-based Ivantis Inc. said it raised $25 million in its second round of financing. It said it plans to use the money to support ongoing clinical trials for its Hydrus microstent, which is implanted into the eye to treat glaucoma. Glaucoma is a major cause of blindness around the world.
Senate Divided on Levy Meant to Boost Reform
One of the medical device industry’s favorite topics—repealing a federal tax on its companies’ revenues—has resurfaced yet again in Congress.
Aliso Viejo-based Microsemi Corp. said that James V. Mazzo has resigned from its board of directors.